TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.090
+0.030 (2.83%)
At close: Jul 10, 2026, 4:00 PM EDT
1.101
+0.011 (1.05%)
Pre-market: Jul 13, 2026, 4:06 AM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $71.23 million as of July 13, 2026. Its market cap has decreased by -18.26% in one year.
Market Cap
71.23M
Enterprise Value
35.71M
1-Year Change
-18.26%
Ranking
Category
Stock Price
$1.09
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $71.23M, a decrease of -80.16%. That is a compound annual growth rate of -27.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 71.23M | 25.52% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gain Therapeutics | 76.78M |
| iBio, Inc. | 75.01M |
| OS Therapies | 74.82M |
| MindWalk Holdings | 71.02M |
| XBiotech | 69.82M |
| Pliant Therapeutics | 68.82M |
| MediciNova | 68.42M |
| ImageneBio | 66.66M |